Volume 28, Issue 2, Pages (February 2008)

Slides:



Advertisements
Similar presentations
Volume 121, Issue 4, Pages (May 2005)
Advertisements

Structural Basis for the Highly Selective Inhibition of MMP-13
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Olivier Fisette, Stéphane Gagné, Patrick Lagüe  Biophysical Journal 
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Volume 14, Issue 3, Pages (March 2001)
Volume 20, Issue 10, Pages (October 2013)
Immunodominant-Peptide Recognition: Beta Testing TCRαβ
Volume 35, Issue 5, Pages (November 2011)
Volume 37, Issue 4, Pages (October 2012)
Decoy Strategies: The Structure of TL1A:DcR3 Complex
Volume 16, Issue 3, Pages (March 2002)
Yvonne Groemping, Karine Lapouge, Stephen J. Smerdon, Katrin Rittinger 
Volume 24, Issue 8, Pages (August 2016)
Volume 14, Issue 1, Pages (January 2001)
Volume 4, Issue 3, Pages (March 1996)
Structural Basis for an Unexpected Mode of SERM-Mediated ER Antagonism
Ubiquitin Recognition by the Human TSG101 Protein
Crystal Structure at 2.8 Å of an FcRn/Heterodimeric Fc Complex
Volume 30, Issue 3, Pages (March 2009)
Volume 20, Issue 5, Pages (May 2012)
Liqun Zhang, Susmita Borthakur, Matthias Buck  Biophysical Journal 
Volume 22, Issue 1, Pages (January 2005)
Michel A. Cuendet, Olivier Michielin  Biophysical Journal 
Volume 19, Issue 12, Pages (December 2011)
Volume 28, Issue 1, Pages (October 2007)
Volume 35, Issue 1, Pages (July 2011)
Volume 25, Issue 5, Pages e3 (May 2017)
Volume 31, Issue 2, Pages (July 2008)
Molecular Recognition of CXCR4 by a Dual Tropic HIV-1 gp120 V3 Loop
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 24, Issue 10, Pages (October 2016)
A Conformational Switch in the CRIB-PDZ Module of Par-6
Volume 31, Issue 6, Pages (December 2009)
Volume 20, Issue 12, Pages (December 2012)
Volume 31, Issue 1, Pages (July 2009)
Zhenjian Cai, Nabil H. Chehab, Nikola P. Pavletich  Molecular Cell 
Volume 22, Issue 2, Pages (February 2005)
Elizabeth J. Little, Andrea C. Babic, Nancy C. Horton  Structure 
Molecular Mechanism of Lipopeptide Presentation by CD1a
Volume 95, Issue 7, Pages (December 1998)
Volume 7, Issue 4, Pages (April 2005)
The Multiple Mechanisms of T Cell Receptor Cross-reactivity
Structural Basis for the Highly Selective Inhibition of MMP-13
Volume 37, Issue 4, Pages (October 2012)
Volume 22, Issue 2, Pages (February 2014)
Volume 13, Issue 3, Pages (February 2004)
Volume 15, Issue 6, Pages (December 2001)
Volume 24, Issue 5, Pages (May 2016)
Volume 11, Issue 9, Pages (September 2003)
How a Single T Cell Receptor Recognizes Both Self and Foreign MHC
Volume 12, Issue 3, Pages (March 2000)
Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10  Adriana Irimia, Anita Sarkar,
Volume 14, Issue 4, Pages (April 2006)
The Shaping of T Cell Receptor Recognition by Self-Tolerance
Volume 31, Issue 6, Pages (December 2009)
Binding Affinity and Interaction of LL-37 with HLA-C
Volume 87, Issue 7, Pages (December 1996)
Crystal Structure of the Tyrosine Phosphatase SHP-2
Jia-Wei Wu, Amy E. Cocina, Jijie Chai, Bruce A. Hay, Yigong Shi 
Volume 1, Issue 4, Pages (March 1998)
Volume 25, Issue 6, Pages e5 (June 2019)
Volume 9, Issue 6, Pages (December 1998)
Volume 4, Issue 3, Pages (March 1996)
The Structure of T. aquaticus DNA Polymerase III Is Distinct from Eukaryotic Replicative DNA Polymerases  Scott Bailey, Richard A. Wing, Thomas A. Steitz 
Volume 16, Issue 3, Pages (March 2002)
Volume 20, Issue 5, Pages (May 2012)
Structural Basis for Apelin Control of the Human Apelin Receptor
Immunodominant-Peptide Recognition: Beta Testing TCRαβ
The Human Cytomegalovirus UL44 C Clamp Wraps around DNA
Presentation transcript:

Volume 28, Issue 2, Pages 171-182 (February 2008) The Structural Dynamics and Energetics of an Immunodominant T Cell Receptor Are Programmed by Its Vβ Domain  Jeffrey Ishizuka, Guillaume B.E. Stewart-Jones, Anton van der Merwe, John I. Bell, Andrew J. McMichael, E. Yvonne Jones  Immunity  Volume 28, Issue 2, Pages 171-182 (February 2008) DOI: 10.1016/j.immuni.2007.12.018 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 Overview of Structural Changes on Binding (A) Relative shift of the JM22 Vα domain to the JM22 Vβ domain in unliganded (red) and liganded (green) forms. The twist is ∼7.0°. (B) The relative shift on binding in CDR3α loop residues in relation to the Vα domain. (C) The relative shift on binding in CDR3β loop residues in relation to the Vβ domain. (D) Positions of water molecules on the TCR binding surface from HLA-A2-flu unliganded (orange) and from HLA-A2-flu complexed to JM22 (blue), within 3.0 Å of pMHC and TCR. (E) The relative temperature-factor changes for the unliganded JM22 and HLA-A∗0201-flu (left) compared to the 1.4 Å resolution JM22-HLA-A∗0201-flu complex (right), colored from red (highest B factor) to blue (lowest B factor) for main-chain atoms. Immunity 2008 28, 171-182DOI: (10.1016/j.immuni.2007.12.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 General Overview of JM22 Contact Residues and the Effects of Mutations on Affinity for HLA-A2-flu (A) Looking down at the HLA-A2-flu ligand, the peptide in yellow can be seen to sit between the alpha helices of HLA-A2 in white. Portions of the CDR loops of the JM22 TCR that contact the HLA-A2-flu ligand are colored and labeled accordingly with CDR1α in pink, CDR3α in turquoise, CDR1β in green, CDR2β in magenta, CDR3β in blue. The CDR2α loop is excluded from the figure because it makes no direct contacts to the peptide and minimal contacts to HLA-A2. (B) Severity of the effects of mutations on KD are colored according to a spectrum from adverse effects in red, orange, and yellow to mild effects in green and blue. CDR3α residues that make main-chain contacts only at the interface and were therefore not mutated are colored gray. (C) Critical residues involved in direct and water-mediated hydrogen bonds to peptide and HLA-A2 at the interface including Q58β, Q52β, S99β, R98β, and D32β. (D) Hydrogen-bond network maintained by N55β and D56β. (E) CDR1α residues S31α, S32α, and Q34α maintain a water network stabilizing R98β. (F) The side chains of CDR3α residues A93α, G94α, and S95α. Q96α and G97α make no direct contact to peptide or HLA-A2 and thus were not selected for mutation. HLA-A2 is depicted in white, peptide (GILGFVFTL) in yellow, CDR1α in pink, CDR3α in turquoise, CDR1β in green, CDR2β in magenta, and CDR3β in blue. Immunity 2008 28, 171-182DOI: (10.1016/j.immuni.2007.12.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 The Variation of koff with Temperature for the Wild-Type and Mutant Receptors JM22 Binding HLA-A2-flu The high-activation enthalpies of dissociation for WT and mutant JM22 binding (see Δ‡HD in Table 3) lead to large absolute differences at higher temperatures. At 37°C (310.15 K), the koff for WT and S99βA JM22 TCR are estimated to be 1.5 s−1 and 4 s−1, respectively (Table 2). Immunity 2008 28, 171-182DOI: (10.1016/j.immuni.2007.12.018) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 Structural Variation of the JM22:HLA-A2-flu Complex (A) Relative orientation (tilt) of JM22 on HLA-A2-flu for three different crystal forms: 1.4 Å (green), 2.4 Å (magenta), and 2.5 Å (blue). Although for the viewpoint of this panel the JM22 tilt in the 2.5 Å complex appears intermediate between that in the other two complexes, this complex has an additional tilt component into the plane of the paper. (B) With the program Hingefind, CDR3β of the immunodominant Vβ17 chain was identified as the pivot-point of the “rocking” motion; the schematic shows the 1.4 Å complex structure (gray) and the 2.4 Å structure (Vα in red and Vβ in blue). (C) A comparison of the structures of the CDR2β loop (main chain and I53β side chain) and their interaction with the α1 helix of HLA-A2 for the 1.4 Å and 2.4 Å crystal forms. The flexion of the α1 helix at the CDR2β loop interface is not accompanied by any marked conformational changes in the helix-residue side chains, and these are therefore omitted for clarity. Immunity 2008 28, 171-182DOI: (10.1016/j.immuni.2007.12.018) Copyright © 2008 Elsevier Inc. Terms and Conditions